AIM IMMUNOTECH INC. Debt Conversion, Converted Instrument, Amount
AIM IMMUNOTECH INC. (AIM) reported Debt Conversion, Converted Instrument, Amount of $1.24 million for the 12-month period ending 2019-12-31, per its 10-K filed 2020-03-30.
Discontinued › Cash Flow › Financing Activities
us-gaap:DebtConversionConvertedInstrumentAmount1 · last filed 2020-03-30
- AIM IMMUNOTECH INC. debt conversion, converted instrument, amount for the quarter ending 2019-12-31 was -$238.00K.
- AIM IMMUNOTECH INC. debt conversion, converted instrument, amount for the quarter ending 2019-09-30 was $1.00K.
- AIM IMMUNOTECH INC. debt conversion, converted instrument, amount for fiscal 2019 was $1.24M, a 1371.43% increase from fiscal 2018.
- AIM IMMUNOTECH INC. debt conversion, converted instrument, amount for fiscal 2018 was $84.00K.
| Period end | Debt Conversion, Converted Instrument, Amount 3 month | Debt Conversion, Converted Instrument, Amount 6 month | Debt Conversion, Converted Instrument, Amount 9 month | Debt Conversion, Converted Instrument, Amount 12 month |
|---|---|---|---|---|
| 2019-12-31 | -$238.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30 | -$237.00K derived: sum of 2 quarters · filed 2020-03-30 | $1.24M 10-K · filed 2020-03-30 | |
| 2019-09-30 | $1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | $1.47M 10-Q · filed 2019-11-14 | ||
| 2019-06-30 | $1.47M 10-Q · filed 2019-08-14 | |||
| 2018-12-31 | $84.00K 10-K · filed 2019-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |